Viemed Healthcare (VMD) Asset Writedowns and Impairment (2018 - 2023)

Viemed Healthcare (VMD) has 6 years of Asset Writedowns and Impairment data on file, last reported at -$4.1 million in Q2 2023.

• Quarterly Asset Writedowns and Impairment rose 15.05% year-over-year to -$4.1 million in Q2 2023, while the trailing twelve-month figure through Mar 2023 was -$732000.0 (down 107.08% YoY) and the FY2022 annual result came in at -$1.4 million, down 120.57% from the prior year.
• Asset Writedowns and Impairment slipped to -$4.1 million in Q2 2023, from $4.1 million in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $9.1 million in Q4 2020 to a low of -$6.9 million in Q4 2019.
• A 5-year average of $972866.7 and a median of $1.7 million in 2019 frame the typical range for Asset Writedowns and Impairment.
• The widest YoY moves for Asset Writedowns and Impairment: up 86225.0% in 2022, down 121675.0% in 2022.
• Tracing VMD's Asset Writedowns and Impairment over 5 years: stood at -$6.9 million in 2019, then surged by 231.41% to $9.1 million in 2020, then tumbled by 81.95% to $1.6 million in 2021, then plunged by 395.62% to -$4.9 million in 2022, then climbed by 15.05% to -$4.1 million in 2023.
• The last three Asset Writedowns and Impairment figures came in at -$4.1 million (Q2 2023), $4.1 million (Q1 2023), and -$4.9 million (Q2 2022), per Business Quant data.